Review: Screening mammography reduces risk for breast cancer mortality but increases other risks in women 40 to 49 years of age
- Radiologist-performed hand-held ultrasound screening at average risk of breast cancer: results from a single health screening center. Chang, Jung Min; Koo, Hye Ryoung; Moon, Woo Kyung // Acta Radiologica;Jun2015, Vol. 56 Issue 6, p652
The article discusses the use of mammography (MG) to detect breast cancer in women in the U.S. wherein MG help reduce the mortality rates through the early detection of breast cancer. It states that breast cancer were detected through the presence of multiple nodules in cancer patients. It also...
- Review: Screening mammography reduces risk for breast cancer mortality but increases other risks in women 40 to 49 years of age: COMMENTARY. Ramachandran, Venhat; Hillner, Bruce E. // ACP Journal Club;Sept/Oct2007, Vol. 147 Issue 2, p30
The article discusses the effects of serially screening of women 40 to 49 years of age with mammography. It is mentioned that mammography is effective in detection of early stage breast cancer and reduces the rate of mortality. The disadvantage of screening younger women not showing symptoms of...
- Contribution of Early Detection and Adjuvant Treatments to Breast Cancer Mortality Reduction in Catalonia, Spain. Vilaprinyo, Ester; Puig, Teresa; Rue, Montserrat // PLoS ONE;Jan2012, Vol. 7 Issue 1, p1
Background: Reductions in breast cancer (BC) mortality in Western countries have been attributed to the use of screening mammography and adjuvant treatments. The goal of this work was to analyze the contributions of both interventions to the decrease in BC mortality between 1975 and 2008 in...
- Breast Carcinoma In Situ: Risk Factors and Screening Patterns. Claus, Elizabeth B.; Stowe, Meredith; Carter, Darryl // JNCI: Journal of the National Cancer Institute;12/5/2001, Vol. 93 Issue 23, p1811
Examines the risk factor of breast carcinoma. Application of hormone replacement therapy; Use of mammography screening; Observation of radiation therapy.
- Forgoing hormone therapy did not increase mortality for some breast cancer patients. // Hem/Onc Today;10/10/2011, Vol. 12 Issue 19, p16
The article reports on a study which found that adjuvant endocrine therapy does not reduce the risk of mortality in patients with very small, node-negative hormone receptor-positive breast cancer because the risk of mortality in these patients is already extremely low.
- Mammography Screening: Are Women Really Giving Informed Consent? Baines, Cornelia J. // JNCI: Journal of the National Cancer Institute;10/15/2003, Vol. 95 Issue 20, p1508
Presents a review of literature on the relationship between mammography screening and mortality from breast cancer. Evidence for an increased number of deaths from breast cancer in the groups invited to screening instead of the expected reduction in deaths; Data showing that most women...
- Mammography Screening: Are Women Really Giving Informed Consent? (Counterpoint). Berg, Alfred O. // JNCI: Journal of the National Cancer Institute;10/15/2003, Vol. 95 Issue 20, p1511
Comments on the article 'Mammography screening: Are women really giving informed consent,' published in the October 15, 2003 issue of the 'Journal of the National Cancer Institute.' Overviews supporting a lack of mortality benefit of mammography for younger women.
- The effect of HRT on mammograms: does stopping long-term HRT for four weeks significantly improve the quality of screening mammograms? Weaver, K; Glasier, A; Muir, B; Murray, J; Anderson, E // Journal of the British Menopause Society;2004 Supplement, Vol. 10, p17
An abstract of the article "The effect of HRT on mammograms: does stopping long-term HRT for four weeks significantly improve the quality of screening mammograms?" by K. Weaver, A. Glasier, B. Muir, J. Murray, and E. Anderson is presented. It presents a study which investigates the increased...
- The Effect of Estrogen Plus Progestin Hormone Therapy on Breast Cancer Mortality: Still Unresolved. Schairer, Catherine; Brinton, Louise A. // JNCI: Journal of the National Cancer Institute;4/17/2013, Vol. 105 Issue 8, p513
The article discusses the effect of estrogen and progestin hormone therapy on mortality among patients with breast cancer. Studies from the Women's Health Initiative Randomized Trial (WHIRT) presented findings about increased breast cancer incidence associated with the treatment regimen. Other...